A phage-resistant variant of Phase II Shigella sonnei has been isolated and the type-specific antigen from it has been obtained. 2. The antigen of the variant microorganism, II/3, 4, 7, differs from that of the parent Phase II bacillus in serological specificity and in chemical make-up. 3. Although the antigen of Phase II Sh. sonnei inhibits all T phages to which the bacillus is susceptible, that of the variant fails to inhibit T(3), T(4), and T(7).
No takes yet. Share an insight, caveat, or question.
Goebel et al. (1952) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: